Wednesday 23 August 2017

Pharma entrepreneurs Brennan (47) and Carney (52) set up Wexford-headquartered Eirgen 10 years ago to target the production of generic formulation of niche cancer drugs.

Last May New York-listed drug firm Opko splashed out €124m to buy the company, this included €91.6m in cash with the €32.4m in shares. Waterford-based Brennan and Tipperary-based Carney owned just over 25pc of the company.

Online Editors

Also in Business